ICU Medical (ICUI) Sets New 1-Year High and Low at $307.92

Shares of ICU Medical, Incorporated (NASDAQ:ICUI) hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $307.92 and last traded at $306.45, with a volume of 1947 shares changing hands. The stock had previously closed at $306.10.

Several analysts recently issued reports on the stock. ValuEngine upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 2nd. TheStreet lowered shares of ICU Medical from an “a” rating to a “c+” rating in a report on Wednesday, May 9th. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, March 7th. Finally, Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $311.00 price objective on the stock in a report on Wednesday, May 16th. One equities research analyst has rated the stock with a hold rating, one has assigned a buy rating and three have issued a strong buy rating to the stock. ICU Medical currently has an average rating of “Buy” and a consensus price target of $311.00.

The stock has a market cap of $5.90 billion, a price-to-earnings ratio of 56.07 and a beta of 0.36.



ICU Medical (NASDAQ:ICUI) last released its earnings results on Wednesday, May 9th. The medical instruments supplier reported $2.26 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.42. The company had revenue of $372.00 million during the quarter, compared to the consensus estimate of $346.28 million. ICU Medical had a return on equity of 9.55% and a net margin of 1.25%. ICU Medical’s revenue was up 50.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.68 EPS. analysts anticipate that ICU Medical, Incorporated will post 6.66 EPS for the current fiscal year.

In other ICU Medical news, Director George A. Lopez sold 12,600 shares of ICU Medical stock in a transaction dated Monday, June 4th. The stock was sold at an average price of $293.17, for a total value of $3,693,942.00. Following the completion of the transaction, the director now directly owns 426,016 shares of the company’s stock, valued at approximately $124,895,110.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director George A. Lopez sold 7,640 shares of ICU Medical stock in a transaction dated Wednesday, March 21st. The shares were sold at an average price of $253.83, for a total value of $1,939,261.20. Following the completion of the transaction, the director now directly owns 526,574 shares of the company’s stock, valued at $133,660,278.42. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 148,886 shares of company stock valued at $39,614,760. 12.50% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. grew its position in shares of ICU Medical by 65.0% during the first quarter. Point72 Asset Management L.P. now owns 200,256 shares of the medical instruments supplier’s stock worth $50,545,000 after buying an additional 78,856 shares in the last quarter. BlackRock Inc. grew its position in shares of ICU Medical by 3.4% during the fourth quarter. BlackRock Inc. now owns 1,879,874 shares of the medical instruments supplier’s stock worth $406,052,000 after buying an additional 62,605 shares in the last quarter. Redmile Group LLC grew its position in shares of ICU Medical by 38.2% during the first quarter. Redmile Group LLC now owns 193,472 shares of the medical instruments supplier’s stock worth $48,832,000 after buying an additional 53,500 shares in the last quarter. Castleark Management LLC grew its position in shares of ICU Medical by 3,016.5% during the fourth quarter. Castleark Management LLC now owns 51,110 shares of the medical instruments supplier’s stock worth $11,040,000 after buying an additional 49,470 shares in the last quarter. Finally, Northern Trust Corp grew its position in shares of ICU Medical by 21.3% during the first quarter. Northern Trust Corp now owns 246,976 shares of the medical instruments supplier’s stock worth $62,337,000 after buying an additional 43,410 shares in the last quarter. 72.23% of the stock is owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply